Antibody response to an eleven valent diphtheria- and tetanus-conjugated pneumococcal conjugate vaccine in Filipino infants
- 1 April 2002
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 21 (4) , 309-314
- https://doi.org/10.1097/00006454-200204000-00010
Abstract
Pneumococcal conjugate vaccines are intended to provide effective protection against pneumococcal infections, but very little information on antibody responses in infants living in countries with high pneumococcal disease burden exists. In this study 50 healthy Filipino infants were enrolled at a village health center in Cabuyao to receive 11-valent diphtheria- and tetanus-conjugated pneumococcal vaccine at 6, 10 and 14 weeks of age (primary series) simultaneously with diphtheria-tetanus-whole cell pertussis/polyribosylribitol phosphate conjugated to tetanus toxoid, hepatitis B virus and oral poliovirus vaccines and at 9 months of age (booster dose) simultaneously with measles vaccine. The alum-adjuvanted study vaccine contained pneumococcal polysaccharide of serotypes 1, 4, 5, 7F, 9V, 19F and 23F conjugated to tetanus protein and pneumococcal polysaccharide of serotypes 3, 6B, 14 and 18C conjugated to diphtheria toxoid. Serum samples for enzyme immunoassay analyses were collected at 6, 10 and 14 weeks and 9 and 10 months of age. Very high geometric mean antibody concentrations (GMCs) against most pneumococcal serotypes were observed after the first three doses of vaccine (range, serotype 23F, 3.89 μg/ml to serotype 4, 23.41 μg/ml) with the exception of serotype 6B and 14, with GMCs of 1.12 and 2.18 μg/ml, respectively. The fourth dose increased the GMCs against most serotypes (range, serotype 14, 1.65 to serotype 19F, 33.43 μg/ml). The maternally derived antibodies did not decrease the response to the vaccine. This first pneumococcal conjugate vaccine study in Asia confirms that the 11-valent diphtheria- and tetanus-conjugated pneumococcal vaccine is highly immunogenic in Filipino infants. The GMCs against most pneumococcal serotypes were substantially higher than described with the same or other pneumococcal conjugate vaccines in other populations.Keywords
This publication has 24 references indexed in Scilit:
- Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of lifeThe Pediatric Infectious Disease Journal, 2001
- Magnitude of the problem of childhood pneumoniaThe Lancet, 1999
- Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid1Presented in part at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 1995 and the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, September 1996.1Vaccine, 1999
- Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhoodVaccine, 1999
- Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memoryThe Pediatric Infectious Disease Journal, 1998
- Immunogenicity of heptavalent pneumococcal conjugate vaccine in infantsThe Journal of Pediatrics, 1996
- Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infantsThe Pediatric Infectious Disease Journal, 1996
- Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine Is Immunogenic in Infants and ChildrenThe Journal of Infectious Diseases, 1995
- Etiology of severe pneumonia in children in developing countriesThe Pediatric Infectious Disease Journal, 1986
- The Bacteriology of Acute Otitis Media in Children with Special Reference to Streptococcus Pneumoniae as Studied by Bacteriological and Antigen Detection MethodsScandinavian Journal of Infectious Diseases, 1981